高级检索
李冰, 李博, 周长林. 基于抗耐药性细菌感染的抗菌肽研究进展[J]. 中国药科大学学报, 2014, 45(5): 580-586. DOI: 10.11665/j.issn.1000-5048.20140514
引用本文: 李冰, 李博, 周长林. 基于抗耐药性细菌感染的抗菌肽研究进展[J]. 中国药科大学学报, 2014, 45(5): 580-586. DOI: 10.11665/j.issn.1000-5048.20140514
LI Bing, LI Bo, ZHOU Changlin. Progress on antimicrobial peptides against drug-resistant bacterial infection[J]. Journal of China Pharmaceutical University, 2014, 45(5): 580-586. DOI: 10.11665/j.issn.1000-5048.20140514
Citation: LI Bing, LI Bo, ZHOU Changlin. Progress on antimicrobial peptides against drug-resistant bacterial infection[J]. Journal of China Pharmaceutical University, 2014, 45(5): 580-586. DOI: 10.11665/j.issn.1000-5048.20140514

基于抗耐药性细菌感染的抗菌肽研究进展

Progress on antimicrobial peptides against drug-resistant bacterial infection

  • 摘要: 随着抗生素的发现及滥用,耐药细菌感染已威胁到了人们的健康,现有抗生素已不能满足临床治疗的需求。因此,解决这一问题已迫在眉睫。本文针对耐药细菌的耐药机制及抗菌肽(antimicrobial peptides,AMPs)这一新型广谱抗菌药物的研究进展进行了综述。

     

    Abstract: Drug-resistant bacteria from long term use of antibiotics have been threatened human health. The antibiotics now available cannot meet the needs for clinical treatment of drug-resistant bacteria, therefore, it has been a great challenge to find solutions to the problem. This article summarizes the resistance mechanisms of drug-resistant bacteria and reviews the development of a new broad-spectrum antibacterial agent named antimicrobial peptides(AMPs).

     

/

返回文章
返回